HEALTH● LOW1h ago · Oct 7, 2026, 5:30 PM
Pfizer’s Tukysa regimen approved in U.S. for front-line breast cancer
Seeking Alpha Tech · north america
Pfizer's Tukysa regimen has received approval in the U.S. for use as a front-line treatment for breast cancer. This represents a new treatment option for patients.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH21m agoCanada will not allow assisted suicide for those with only mental illnessVanguard NigeriaHEALTH41m agoCanada Halts Plan to Allow Medically Assisted Death for the Mentally IllNYT WorldHEALTH46m agoKenya on high alert amid concern over screening after first Ebola deathAl Jazeera [en]HEALTH1h agoHealth Review: Ebola alert, Lassa fever deaths, maternal health push, other developments that shaped SeptemberPremium Times